These novel therapies, including Wegovy, Mounjaro , and Zaxig , represent a significant advancement in addressing type 2 the condition and assisting with weight management. They function by emulating the body’s natural peptide GLP-1 , enabling to moderate blood sugar and reduce appetite . The therapy has somewhat unique qualities and may be suita